Novartis is seeking a Principal Scientist I/II for their Oncology Translational Research group in Cambridge, MA. The role involves leading a team to investigate mechanisms of efficacy and resistance to radioligand therapy, requiring strong expertise in cancer biology and collaboration across various drug development teams.
Base: $108,500 - $201,500; Bonus/Equity: performance-based cash incentive and annual equity awards; Benefits: comprehensive benefits package including health, life and disability benefits, a 401(k) with company contribution and match, and generous time off
Must-have
Nice-to-have
Not specified